| Old Articles: <Older 6171-6180 Newer> |
|---|
 |
The Motley Fool
February 2, 2010
Brian Orelli |
Shaking Up the Biotech Industry A judge will decide if genes are patentable or not.   |
The Motley Fool
February 2, 2010
Brian Orelli |
Foolish Forecast: First Look at Pfizer Plus With the addition of Wyeth last quarter, there's no doubt Pfizer is larger, but whether that bigger size translates into savings that boosts profits remains to be seen. |
InternetNews
February 1, 2010 |
Apple's iPad a Boon to Health Care Providers? Steve Jobs didn't mention it at the product's debut, but the iPad's specs and design position it as a good point-of-care device for health care professionals and telemedicine applications. |
The Motley Fool
February 1, 2010
Brian Orelli |
Now That's Some Expensive Risk Mitigation Boston Scientific avoids a trial -- but at a dear cost. |
CRM
February 2010
Lauren McKay |
The New-Age Home Aided by SiteSpect, a specialist in elder-care placement boosts Web conversions and better addresses client needs. |
The Motley Fool
January 29, 2010
Brian Orelli |
How to Make Billions of Dollars Without Really Trying Lackluster Alzheimer's drugs have been doing it for years. |
The Motley Fool
January 29, 2010
Brian Orelli |
Wake Up! You Still Have to Pay Attention We already knew Celgene's preliminary numbers, but the conference call offers a look ahead. |
The Motley Fool
January 29, 2010
Brian Orelli |
Icahn Back to Batter Biogen The old guy has tenacity. |
The Motley Fool
January 29, 2010
Brian Orelli |
All Grown Up, With Cash to Burn Bristol-Myers is all drugs, all the time. |
Chemistry World
January 28, 2010
Nina Notman |
AstraZeneca's workforce slashed again Pharma giant AstraZeneca is to cut another 8,000 jobs globally over the next four years - with approximately 1,800 additional research and development staff to be lost. |
| <Older 6171-6180 Newer> Return to current articles. |
